Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Immediately after opening, your secured card can influence factors like payment history and utilization. Here’s what to expect in the first months.
19,050 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...
Tesla's robotaxi venture is facing real-world hurdles in Texas. This article breaks down what those problems mean for...
Nvidia just delivered another earnings beat and a bold $80 billion buyback. As AI infrastructure spending accelerates...
Looking a decade ahead, two large, resilient shares stand out. This article explains why NVIDIA and Microsoft are pri...
Cerebras stock priced at a premium can be tough for everyday investors. This guide shows how an AI-focused ETF offers...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
A rare glimpse of a celebrity family becomes a blueprint for everyday money choices. This article unpacks how privacy...
Sui faced back-to-back outages, pushing the token to a 20% weekly slide. This piece breaks down what happened, why it...
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
A regulatory nod sparks a wave of excitement across crypto markets. Perpetual futures are back in the spotlight as tr...
Greg Abel is steering Berkshire’s AI strategy with a sizable move into Alphabet. This bold bet highlights how mega-ca...